We recombined the full-length PCSK9 cDNA into pGEX-4T-1, purified the GST-PCSK9 protein, and examined the s-PCSK9-Ab levels in patients with esophageal cancer, gastric cancer, colorectal cancer, lung cancer, and breast cancer. This evidence concerns the gene PCSK9 and breast carcinoma.